| Patient | Florence Griffith Joyner |
|---|---|
| Date of birth | 1959-12-21 |
| Identifiers | MRN HR-ML033-SYN-TD; SSN (made up) 000-33-2648 |
| Document date | 2026-11-01 |
| Author | Celeste Vanterpool, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two and a half weeks after a generalized seizure on a flight: history, examination, laboratory screen, EEG and MRI ordered, driving and safety advice, and neurology (epilepsy) review booked. Concerns: A seizure on a flight two and a half weeks ago, after which she was kept in hospital overnight; she remembers nothing of the seizure itself and wants to understand what happened; She wants to know why it happened and how to stop it happening again, and whether she can keep training, driving and flying; She wants the details kept private. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily | One tablet twice daily | Oral route | 1996-05-05 | active | S |
| Folic acid 0.4 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1996-05-05 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 1996-06-16 to 1996-06-30 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Routine EEG with sleep deprivation the night before, awake and asleep, with hyperventilation and photic stimulation: intermittent left frontal sharp waves and focal slowing (maximum F7 and Fp1); no generalized discharges; no seizure recorded | 1996-04-24 to 1996-04-24 | completed | S |
| MRI of the brain, epilepsy protocol, with susceptibility-weighted imaging and gadolinium: a 1.4 cm mulberry-like lesion in the left orbitofrontal cortex with mixed signal and a complete hemosiderin rim (cavernous malformation, Zabramski type II), an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging, and no acute hemorrhage or edema | 1996-04-28 to 1996-04-28 | completed | S |
| Advance care planning conversation, about 15 minutes | 1996-08-25 to 1996-08-25 | completed | S |
| Left frontal craniotomy with neuronavigation for complete excision of the orbitofrontal cavernous malformation with the surrounding hemosiderin-stained brain, sparing the developmental venous anomaly; no complications; home on the third day. Pathology: cavernous malformation (closely packed, thin-walled vascular channels without intervening brain, with old hemorrhage and hemosiderin in the surrounding gliotic tissue) | 1996-06-16 to 1996-06-16 | completed | S |
| MRI of the brain the day after surgery: complete resection of the cavernous malformation and the hemosiderin rim; expected postoperative changes; developmental venous anomaly preserved; no hemorrhage or infarct | 1996-06-17 to 1996-06-17 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1996-08-25 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1990 to 1994 | Treated for seizures in 1990, 1993 and 1994, as reported from the coroner's records after her death; details not public | D (CLM-0006) |
| April 1996 | Seizure on a flight in April 1996; discharged from hospital the next day; the family asked that no other details be released | D (CLM-0005) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| A seizure on a flight two and a half weeks ago, after which she was kept in hospital overnight; she remembers nothing of the seizure itself and wants to understand what happened | active | S |
| She wants to know why it happened and how to stop it happening again, and whether she can keep training, driving and flying | active | S |
| She wants the details kept private | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 13.4 on 1996-04-22; Leukocytes [#/volume] in Blood by Automated count 6.1 on 1996-04-22; Platelets [#/volume] in Blood by Automated count 238 on 1996-04-22; Sodium [Moles/volume] in Serum or Plasma 140 on 1996-04-22; Potassium [Moles/volume] in Serum or Plasma 4.1 on 1996-04-22; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1996-04-22; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M 83 on 1996-04-22; Glucose [Mass/volume] in Serum or Plasma 86 on 1996-04-22; Calcium [Mass/volume] in Serum or Plasma 9.6 on 1996-04-22; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 on 1996-04-22; Magnesium [Mass/volume] in Serum or Plasma 2 on 1996-04-22; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 168 on 1996-04-22; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1996-08-25; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 6 on 1996-04-22; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1996-10-20 [S]
Strengths and supports: Married, with a young child; household members are not named and have no role in this record. Supports: her household, her training community, and the young athletes she works with [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no driving | resolved | confirmed | R56.9 | S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation. |
| Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 1984 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner's finding | active | confirmed | G40.209 | S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D). |
| Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhage | resolved | confirmed | Q28.3 | S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D). |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1996-04-22 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 12-15.5 g/dL | Normal | S |
| 1996-04-22 | Leukocytes [#/volume] in Blood by Automated count | 6.1 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1996-04-22 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1996-04-22 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1996-04-22 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1996-04-22 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1996-04-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M | 83 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1996-04-22 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 1996-04-22 | Calcium [Mass/volume] in Serum or Plasma | 9.6 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1996-04-22 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 17 | U/L | 7-35 U/L | Normal | S |
| 1996-04-22 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1996-04-22 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 168 | U/L | 26-192 U/L | Normal | S |
| 1996-04-22 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1996-04-22 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S | ||
| 1996-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1996-05-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1996-07-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1996-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1996-08-25 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1996-04-22 | Body height | 170 | cm | S |
| 1996-04-22 | Body weight | 61 | kg | S |
| 1996-04-22 | Body mass index (BMI) [Ratio] | 21.1 | kg/m2 | S |
| 1996-04-22 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1996-04-22 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1996-04-22 | Heart rate | 56 | /min | S |
| 1996-04-22 | Respiratory rate | 14 | /min | S |
| 1996-04-22 | Body temperature | 36.7 | Cel | S |
| 1996-04-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1996-05-05 | Body height | 170 | cm | S |
| 1996-05-05 | Body weight | 61.2 | kg | S |
| 1996-05-05 | Body mass index (BMI) [Ratio] | 21.2 | kg/m2 | S |
| 1996-05-05 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1996-05-05 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1996-05-05 | Heart rate | 58 | /min | S |
| 1996-05-05 | Respiratory rate | 14 | /min | S |
| 1996-05-05 | Body temperature | 36.6 | Cel | S |
| 1996-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1996-05-27 | Body height | 170 | cm | S |
| 1996-05-27 | Body weight | 60.8 | kg | S |
| 1996-05-27 | Body mass index (BMI) [Ratio] | 21 | kg/m2 | S |
| 1996-05-27 | Systolic blood pressure | 114 | mm[Hg] | S |
| 1996-05-27 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1996-05-27 | Heart rate | 60 | /min | S |
| 1996-05-27 | Respiratory rate | 14 | /min | S |
| 1996-05-27 | Body temperature | 36.7 | Cel | S |
| 1996-05-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1996-07-21 | Body height | 170 | cm | S |
| 1996-07-21 | Body weight | 60.1 | kg | S |
| 1996-07-21 | Body mass index (BMI) [Ratio] | 20.8 | kg/m2 | S |
| 1996-07-21 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1996-07-21 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1996-07-21 | Heart rate | 62 | /min | S |
| 1996-07-21 | Respiratory rate | 14 | /min | S |
| 1996-07-21 | Body temperature | 36.6 | Cel | S |
| 1996-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1996-10-20 | Body height | 170 | cm | S |
| 1996-10-20 | Body weight | 60.9 | kg | S |
| 1996-10-20 | Body mass index (BMI) [Ratio] | 21.1 | kg/m2 | S |
| 1996-10-20 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1996-10-20 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1996-10-20 | Heart rate | 54 | /min | S |
| 1996-10-20 | Respiratory rate | 14 | /min | S |
| 1996-10-20 | Body temperature | 36.6 | Cel | S |
| 1996-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1996-08-25 | Body height | 170 | cm | S |
| 1996-08-25 | Body weight | 60.6 | kg | S |
| 1996-08-25 | Body mass index (BMI) [Ratio] | 21 | kg/m2 | S |
| 1996-08-25 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1996-08-25 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1996-08-25 | Heart rate | 56 | /min | S |
| 1996-08-25 | Respiratory rate | 14 | /min | S |
| 1996-08-25 | Body temperature | 36.6 | Cel | S |
| 1996-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1996-04-22 | Two and a half weeks after a generalized seizure on a flight: history, examination, laboratory screen, EEG and MRI ordered, driving and safety advice, and neurology (epilepsy) review booked | finished | S |
| 1996-05-05 | EEG and MRI results: focal epilepsy from a left orbitofrontal cavernous malformation; epilepsy consultation, levetiracetam with folic acid, and neurosurgical opinion requested | finished | S |
| 1996-05-27 | Three weeks on levetiracetam: mood and side effects, the neurosurgical opinion and surgery date, SUDEP and safety counseling | finished | S |
| 1996-07-21 | Five weeks after lesionectomy: recovery, seizure control, return to training | finished | S |
| 1996-10-20 | Six months after the seizure: seizure freedom, driving review, training, and the long-term plan | finished | S |
| 1996-08-25 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Neurology (epilepsy) consultation within two weeks to interpret the EEG and MRI, decide whether this is epilepsy, and advise on antiseizure medication, surgery and safety | completed | GL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014 | S |
| Evaluation of a seizure in an adult: history from her and witnesses' accounts, examination, blood count, electrolytes, glucose, calcium, magnesium, kidney and liver tests and creatine kinase, a pregnancy test, a sleep-deprived EEG, and MRI of the brain with an epilepsy protocol including susceptibility-weighted imaging; records of her earlier seizure care requested | completed | GL-AAN-FIRSTSZ-2015 | S |
| Safety from today: no driving, and the report of a disorder characterized by lapses of consciousness that California requires of physicians, explained to her before it is sent; no swimming alone or bathing in a tub, showers instead; no heights or working alone near water; seizure first aid and a written seizure action plan, calling emergency services for a seizure lasting five minutes or more | completed | GL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015 | S |
| Levetiracetam 500 mg twice daily, chosen for a woman who could become pregnant (low risk of birth defects, no interaction with hormonal contraception), with folic acid 0.4 mg daily; valproate avoided because of its risk of major malformations and lower intelligence in children exposed in pregnancy; contraception and pregnancy planning discussed; mood and irritability checked with the PHQ-9 at each visit | completed | GL-AAN-TERATO-2024, GL-AAN-FIRSTSZ-2015, GL-ILAE-DEF-2014 | S |
| Neurosurgical evaluation of the epileptogenic cavernous malformation, with lesionectomy including the hemosiderin rim if she chooses it | completed | GL-CCM-2017 | S |
| SUDEP counseling as the AAN/AES guideline requires: what it is, that tonic-clonic seizures are the main risk, and how to lower it (take every dose, keep regular sleep, avoid alcohol excess, aim for no tonic-clonic seizures); nocturnal supervision or a seizure detection watch | completed | GL-AAN-SUDEP-2017, GL-ILAE-DETECT-2021 | S |
| Graded return to training after surgery: walking and stationary cycling from two weeks, running from four to six weeks, sprint sessions from six to eight weeks, full training by three to four months, with no heavy lifting until the craniotomy has healed; swimming only with a companion who knows seizure first aid | completed | GL-CCM-2017, GL-AAN-FIRSTSZ-2015 | S |
| Long term: levetiracetam for at least two years after surgery, then a shared decision about tapering with an EEG; driving when the California DMV clears her after a seizure-free period; MRI only for new symptoms after a complete resection | completed | GL-CCM-2017, GL-CA-DMV-2024, GL-AAN-FIRSTSZ-2015 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| EEG and MRI with susceptibility-weighted imaging within one week, and an epilepsy consultation within two weeks | 1996-05-05 | completed | EEG in two days, MRI in six, consultation at two weeks | S |
| No further seizures on an antiseizure medication she tolerates | 1996-10-20 | completed | No seizure in six months; levetiracetam tolerated after early irritability settled | S |
| Neurosurgical evaluation of the cavernous malformation and a shared decision about lesionectomy within two months | 1996-07-21 | completed | Seen by neurosurgery at three weeks; complete lesionectomy at eight weeks | S |
| Safety plan in place: no driving until cleared, water and height safety, SUDEP discussion, and a nocturnal seizure detection plan | 1996-05-27 | completed | Driving stopped and reported as California requires; SUDEP discussed (one visit late, recorded as a deviation); detection watch in use | S |
| Graded return to full sprint training within four months of surgery | 1996-10-20 | completed | Full training at four months after surgery | S |